Latest Operational Improvements News

IGO Limited reported a robust operational quarter with improved safety and solid production at Greenbushes and Nova, offset by challenges at its Kwinana lithium refinery and an expected asset impairment.

IGO Limited reported robust operational performance in Q4 FY25 with improved safety and higher production at Greenbushes and Nova, while facing significant impairment at its Kwinana lithium refinery.

Spectur Limited reports a positive operating cash flow for Q4 FY25, driven by revenue growth and cost-cutting, alongside strategic investments in cloud and connectivity technology.

Synlait Milk Limited reports a significant financial turnaround for FY25 with expected underlying EBITDA doubling from the prior year, while overcoming manufacturing setbacks at its Dunsandel facility.

Oliver’s Real Food Limited reported a 70% increase in EBIT for the June 2025 quarter, driven by cost-cutting and operational improvements, despite a nearly 6% decline in revenue due to store closures and external factors.

Focus Minerals reported a record gold pour in June 2025 at its Three Mile Hill plant, alongside significant mining progress and infrastructure upgrades at Coolgardie. The company also completed a $250 million sale of its Laverton Gold Project, strengthening its balance sheet.

Nova Eye Medical has reported a record A$29.2 million revenue for FY25, driven by strong sales growth and improved profitability in its glaucoma segment. The company targets breakeven EBITDA in the first half of FY26 alongside continued cash flow improvements.

EQ Resources has locked in a US$7.5 million royalty funding agreement with Oaktree Management, aimed at expanding and enhancing its Barruecopardo tungsten project in Spain. This deal strengthens the company’s balance sheet and supports critical capital projects to increase production capacity.

Atomo Diagnostics reports strong commercial momentum in Q4 FY25, highlighted by a major US supply agreement, rapid growth in HIV self-test sales, and promising data for its syphilis test.

Careteq Limited reports a significant reduction in operating cash outflow and modest revenue growth for FY25, while facing delays in its key platform integration and a dispute with the ATO over R&D claims.

Nova Eye Medical has reported a record A$29.2 million revenue for FY25, driven by strong sales growth and improved profitability in its glaucoma segment. The company targets breakeven EBITDA in the first half of FY26 amid promising regulatory and market developments.

Boss Energy has exceeded its FY25 production and cost targets at the Honeymoon Uranium Project, marking a major milestone of over 1 million pounds of uranium produced since commissioning. The company’s robust balance sheet and operational ramp-up position it well for growth amid a strengthening uranium market.